Fundraising FoxTensorbio
2 known investors
Find your way into Tensorbio
Sign up to see every warm intro you have to Tensorbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tensorbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tensor Bio develops a non-invasive, blood-based test that uses cell-free DNA methylation profiling and machine learning to stage liver fibrosis from a single blood draw. It targets MASH/MASLD diagnosis and monitoring, serving hepatologists, primary care clinicians, and biopharma partners who need to identify patients eligible for approved fibrosis therapies.
Investors · 2
Frequently asked questions
- What does Tensorbio do?
- Tensor Bio develops a non-invasive, blood-based test that uses cell-free DNA methylation profiling and machine learning to stage liver fibrosis from a single blood draw. It targets MASH/MASLD diagnosis and monitoring, serving hepatologists, primary care clinicians, and biopharma partners who need to identify patients eligible for approved fibrosis therapies.
- Who are Tensorbio's investors?
- Tensorbio's investors include Convergent Ventures, Initiate Venture Partners.